Harrow, Inc. (HROW)

NASDAQ: HROW · Real-Time Price · USD

25.69

-0.58 (-2.21%)

May 14, 2025, 10:36 AM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Innovative Ophthalmic Therapies	130.19M	Log In	Log In	Log In	Log In	Upgrade
Innovative Ophthalmic Therapies Growth	46.95%	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Compounding	-	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Compounding Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	130.19M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	46.95%	Log In	Log In	Log In	Log In	Upgrade